6 results
To assess the effectivity and safety of 1.0 molar gadobutrol (Gadovist®) for breast MRI
The primary objective of this study is to obtain clinical proof of principle that the addition of a PgP/BCRP inhibitor increases CNS concentrations of tyrosine kinase inhibitors by inhibition of drug efflux transporter function in the blood brain…
The primary objective is to evaluate the feasibility of early therapeutic effect evaluation by performing early follow up imaging after percutaneous MR-guided cryoablation of pT1a renal cell carcinoma. Secondary objective is to assess the outcomes…
1: determine the additional predictive value of MRI measures of brain connectivity on top of existing clinical parameters for cognitive recovery or deterioration in the first year after stroke.2: assess feasibility of a standardized work*up…
Identification of MRI-based biomarkers to predict clinical outcome of major depressive disorder in comparison with healthy controls. Outcome is defined by level of depressive and cognitive symptomatology and related comorbidity.
To prospectively assess the potential effect of repeated exposure to either a linear or amacrocyclic gadolinium-based contrast agent (GBCA) on change from baseline to Year 5 inmotor and cognitive function among neurologically normal adults in…